Become a donor or member and support our work to advance access to medicines. For everyone. Everywhere
Publications
2012
Heading ACTA and Access to Medicines: Flawed Process, Rationale and Agreement
Protect Access to Medicines: Say “No” to ACTA
Business Conduct Guidelines
Complaints Procedure (EN)
Procedimiento de Querellas
Klachtenprocedure (Complaints Procedure – Dutch)
Unlocking the Mysteries of Access to Clinical Trials Data in the EU
Call to EU Leadership on Global Health Research & Development
2011
Statement on Medicines Patent Pool
Universal Access to Medicines for Non-Communicable Diseases
Drop in Pay-for-Delay Good for Access to Medicines in Europe
Resolution on Innovation and Access to Medical Technologies
Uso Racional: La influencia de la publicidad en el uso del medicamento
Statement on Conflicts of Interests delivered at WHA
Statement on EU India and EU Mercosur Free-Trade Negotiations
Medicines pay-for-delay back under the microscope
Transparency of European Medicines Regulation
2010
Increasing Calls Within the EU for New Models of Medical Innovation
EMA Talks the ‘Conflicts of Interest’ Talk, but Will it Walk the Walk?
EU Citizens Get a Voice in Pharmacovigilance
Как распознавать продвижение лекарств и как к нему относиться: Практическое руководство
Comprender la promoción farmacéutica y responder a ella: Una guía práctica
Understanding & Responding to Pharmaceutical Promotion: A Practical Guide
WHO Should Refocus its Efforts on Wider Public Health Threats
Direct Patient Reporting of Adverse Drug Reactions
HAI Europe is Granted Full Membership by the European Medicines Agency
2009